Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (101-110 of 401) with videos related to

Pageof 41
Sort By:
Circulation. Cardiovascular Genetics|November 17, 2010
First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studiesUdaya S Tantry, Kevin P Bliden, Cheryl Wei, et al.
Thrombosis and Haemostasis|September 19, 2014
How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer?Jolanta M Siller-Matula, Dietmar Trenk, Karsten Schrör, et al.
Diabetes Care|October 18, 2018
Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 DiabetesElaine Chow, Ahmed Iqbal, Emma Walkinshaw, et al.
Journal of Cardiovascular Pharmacology|February 5, 2026
Pharmacokinetic Modeling of Ticagrelor and Ticagrelor Active Metabolite Removal by the DrugSorb-ATR Device in a Randomized Controlled Study of Patients Undergoing Cardiac SurgeryDiane R Mould, Kevin R Sweeney, Jayne Prats, et al.
American Heart Journal|July 12, 2011
The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studiesKevin P Bliden, Udaya S Tantry, Robert F Storey, et al.
Thrombosis and Haemostasis|January 25, 2020
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-StudyWael Sumaya, Lars Wallentin, Stefan K James, et al.
American Heart Journal|September 29, 2014
Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysisDimitrios Alexopoulos, Ioanna Xanthopoulou, Robert F Storey, et al.
The American Journal of Medicine|June 26, 2013
Quantitative ST-depression in acute coronary syndromes: the PLATO electrocardiographic substudyPaul W Armstrong, Cynthia M Westerhout, Yuling Fu, et al.
Platelets|March 8, 2017
Comparison of P2Y<sub>12</sub> inhibitors for mortality and stent thrombosis in patients with acute coronary syndromes: Single center study of 10 793 consecutive 'real-world' patientsRebecca Gosling, Momina Yazdani, Yasir Parviz, et al.
American Heart Journal|September 20, 2015
Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOrDaniel Lindholm, Robert F Storey, Christina Christersson, et al.
Pageof 41

Showing results (101-110 of 401) with videos related to

Sort By:
Pageof 41
Circulation. Cardiovascular Genetics|November 17, 2010
First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studiesUdaya S Tantry, Kevin P Bliden, Cheryl Wei, et al.
Thrombosis and Haemostasis|September 19, 2014
How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer?Jolanta M Siller-Matula, Dietmar Trenk, Karsten Schrör, et al.
Diabetes Care|October 18, 2018
Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 DiabetesElaine Chow, Ahmed Iqbal, Emma Walkinshaw, et al.
Journal of Cardiovascular Pharmacology|February 5, 2026
Pharmacokinetic Modeling of Ticagrelor and Ticagrelor Active Metabolite Removal by the DrugSorb-ATR Device in a Randomized Controlled Study of Patients Undergoing Cardiac SurgeryDiane R Mould, Kevin R Sweeney, Jayne Prats, et al.
American Heart Journal|July 12, 2011
The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studiesKevin P Bliden, Udaya S Tantry, Robert F Storey, et al.
Thrombosis and Haemostasis|January 25, 2020
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-StudyWael Sumaya, Lars Wallentin, Stefan K James, et al.
American Heart Journal|September 29, 2014
Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysisDimitrios Alexopoulos, Ioanna Xanthopoulou, Robert F Storey, et al.
The American Journal of Medicine|June 26, 2013
Quantitative ST-depression in acute coronary syndromes: the PLATO electrocardiographic substudyPaul W Armstrong, Cynthia M Westerhout, Yuling Fu, et al.
Platelets|March 8, 2017
Comparison of P2Y<sub>12</sub> inhibitors for mortality and stent thrombosis in patients with acute coronary syndromes: Single center study of 10 793 consecutive 'real-world' patientsRebecca Gosling, Momina Yazdani, Yasir Parviz, et al.
American Heart Journal|September 20, 2015
Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOrDaniel Lindholm, Robert F Storey, Christina Christersson, et al.
Pageof 41